News | Embolic Protection Devices | April 25, 2023

FastWave Medical Granted Second Utility Patent to Advance the Future of Cardiovascular Calcium Treatment

FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the issuance of its second utility patent by the USPTO. This milestone showcases FastWave Medical's unparalleled efficiency in developing novel intravascular lithotripsy (IVL) systems to address the $9 billion market.

FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the issuance of its second utility patent by the USPTO. This milestone showcases FastWave Medical's unparalleled efficiency in developing novel intravascular lithotripsy (IVL) systems to address the $9 billion market.

April 25, 2023 — FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the issuance of its second utility patent by the USPTO. This milestone showcases FastWave Medical's unparalleled efficiency in developing novel intravascular lithotripsy (IVL) systems to address the $9 billion market. 

"Our second utility patent from the USPTO in just over a year highlights the rapid progress our team has made in advancing IVL treatments for cardiovascular calcium," said Scott Nelson, CEO and Co-Founder of FastWave Medical. "Our innovative technology platforms are designed to offer a more efficient, effective, and cost-conscious solution that addresses the current limitations with existing IVL interventions, propelling the industry forward at an unprecedented pace." 

Artery calcification is a critical predictor of adverse cardiac events. With an aging global population and a substantial number of individuals over 70 affected by the disease, the need for effective treatment options has never been more urgent. FastWave's approach addresses this demand, providing cost-effective, minimally invasive solutions that substantially improve upon existing therapeutic options. 

Accomplished interventional cardiologist, Dr. Sarang Mangalmurti, remarked, "Since its introduction, IVL technology has shown immense promise for treating complex calcium. I have high hopes that FastWave’s user-friendly systems will lead to improved clinical outcomes and a meaningful reduction in adverse events." 

For more information: https://fastwavemedical.com 


Related Content

News | Structural Heart

May 24, 2023 — Medtronic announced two-year results of their Harmony Transcatheter Pulmonary Valve (TPV) System, which ...

Home May 24, 2023
Home
News | Structural Heart

May 19, 2023 — Abbott announced late-breaking data that add to the body of clinical evidence supporting the benefits of ...

Home May 19, 2023
Home
News | Structural Heart

May 17, 2023 — Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the ...

Home May 17, 2023
Home
News | Structural Heart

March 16, 2023 — Cardiologists at the UW Medicine Heart Institute recently performed a first-in-the-world procedure ...

Home May 16, 2023
Home
News | Structural Heart

May 16, 2023 — Henry Ford Health Interventional cardiologists William O’Neill, M.D., and Khaldoon Alaswad, M.D., took a ...

Home May 16, 2023
Home
News | Structural Heart

May 15, 2023 — The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will feature ...

Home May 15, 2023
Home
News | Structural Heart

March 31, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's Epic Max ...

Home March 31, 2023
Home
News | Structural Heart

March 14, 2023 — The Society of Thoracic Surgeons (STS) has developed and launched a new risk calculator to estimate the ...

Home March 14, 2023
Home
News | Structural Heart

March 5, 2023 — In patients with heart failure and a poorly functioning heart valve, a minimally invasive procedure ...

Home March 05, 2023
Home
News | Structural Heart

March 4, 2023 — Abbott announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a ...

Home March 04, 2023
Home
Subscribe Now